The relationship between apolipoprotein e 2/3/4 polymorphisms and hypertension: A meta-analysis of six studies comprising 1812 cases and 1762 controls

Hypertension Research

Volumn 32, Issue 12, 2009, Pages 1060-1066

  Niu, Wenquan ^a   Qi, Yue ^b   Qian, Yuesheng ^a   Gao, Pingjin ^a   Zhu, Dingliang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Apolipoprotein E; E2 e3 e4 polymorphism; Meta analysis

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4;

EVIDENCE BASED MEDICINE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; REVIEW; RISK ASSESSMENT; RISK FACTOR;

APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; HUMANS; HYPERTENSION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 73849139729     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2009.164     Document Type: Review

References (32)

1. Hong Y, de Faire U, Heller DA, McClearn GE, Pedersen N. Genetic and environmental influences on blood pressure in elderly twins. Hypertension 1994; 24: 663-670. (Pubitemid 24363961)
2. Marteau JB, Zaiou M, Siest G, Visvikis-Siest S. Genetic determinants of blood pressure regulation. J Hypertens 2005; 23: 2127-12113
3. Harrison M, Maresso K, Broeckel U. Genetic determinants of hypertension: an update. Curr Hypertens Rep 2008; 10: 488-495.
4. Pollex RL, Hegele RA. Copy number variation in the human genome and its implications for cardiovascular disease. Circulation 2007; 115: 3130-3138.
5. Ames RP. Hyperlipidemia in hypertension: causes and prevention. Am Heart J 1991; 122: 1219-1224.
6. Alexander JK. Obesity and coronary heart disease. Am J Med Sci 2001; 321: 215-224.
7. Bennet AM, Di Angelantonio E, Ye Z, Wensley F, Dahlin A, Ahlbom A, Keavney B, Collins R, Wiman B, de Faire U, Danesh J. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 2007; 298: 1300-1311.
8. Olivieri O, Martinelli N, Bassi A, Trabetti E, Girelli D, Pizzolo F, Friso S, Pignatti PF, Corrocher R. ApoE epsilon2/epsilon3/epsilon4 polymorphism, ApoC-III/ApoE ratio and metabolic syndrome. Clin Exp Med 2007; 7: 164-172.
9. Nieminen T, Kähönen M, Viiri LE, Grönroos P, Lehtimäki T. Pharmacogenetics of apolipoprotein E gene during lipid-lowering therapy: lipid levels and prevention of coronary heart disease. Pharmacogenomics 2008; 9: 1475-1486.
10. Thakkinstian A, McEvoy M, Minelli C, Gibson P, Hancox B, Duffy D, Thompson J, Hall I, Kaufman J, Leung TF, Helms PJ, Hakonarson H, Halpi E, Navon R, Attia J. Systematic review and meta-analysis of the association between \{beta\}2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol 2005; 162: 201-211.
11. Kesäniemi YA, Ehnholm C, Miettinen TA. Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest 1987; 80: 578-581.
12. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med 1997; 127: 820-826.
13. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Br Med J 2003; 327: 557-560.
14. Ioannidis JP, Trikalinos TA. Early extreme contradictory estimates may appear in published research: the proteus phenomenon in molecular genetics research and randomized trials. J Clin Epidemiol 2005; 58: 543-549.
15. Katsuya T, Sato N, Asai T, Fukuda M, Takiuchi S, Fu Y, Hanayama R, Moriguchi A, Rakugi H, Higaki J, Ogihara T. Association of polymorphism in the promoter region of the apolipoprotein E gene with diastolic blood pressure in normotensive Japanese. Hypertens Res 2000; 23: 271-275.
16. Stiefel P, Montilla C, Muñiz-Grijalvo O, García-Lozano R, Alonso A, Miranda ML, Pamies E, Villar J. Apolipoprotein E gene polymorphism is related to metabolic abnormalities, but does not influence erythrocyte membrane lipid composition or sodium-lithium countertransport activity in essential hypertension. Metabolism 2001; 50: 157-160.
17. Katsuya T, Baba S, Ishikawa K, Mannami T, Fu Y, Inamoto N, Asai T, Fukuda M, Higaki J, Ogata J, Ogihara T. Epsilon 4 allele of apolipoprotein E gene associates with lower blood pressure in young Japanese subjects: the Suita Study. J Hypertens 2002; 20: 2017-2021.
18. Imazu M, Yamamoto H, Toyofuku M, Watanabe T, Okubo M, Egusa G, Yamakido M, Kohno N. Association of apolipoprotein E phenotype with hypertension in Japanese-Americans: data from the Hawaii-Los Angeles-Hiroshima Study. Hypertens Res 2001; 24: 523-529. (Pubitemid 33048918)
19. Yilmaz H, Isbir T, Aqaçhan B, Aydin M. Is epsilon4 allele of apolipoprotein E associated with more severe end-organ damage in essential hypertension? Cell Biochem Funct 2001; 19: 191-195.
20. Li X, Du Y, Du Y, Huang X. Association of apolipoprotein E gene polymorphism with essential hypertension and its complications. Clin Exp Med 2003; 2: 175-179. (Pubitemid 36313183)
21. Bhavani AB, Sastry KB, Reddy NK, Padma T. Lipid profile and apolipoprotein E polymorphism in essential hypertension. Indian Heart J 2005; 57: 151-157.
22. Niu W, Guo X, Su Y, Qiu C. Apolipoprotein E and low-density lipoprotein receptor gene polymorphisms in dyslipidemias-associated essential hypertension. J Hum Hypertens 2007; 21: 337-339.
23. Fuzikawa AK, Peixoto SV, Taufer M, Moriguchi EH, Lima-Costa MF. Association of ApoE polymorphisms with prevalent hypertension in 1406 older adults: the Bambuí Health Aging Study (BHAS). Braz J Med Biol Res 2008; 41: 89-94.
24. Peacock ML, Fink JK. ApoE epsilon 4 allelic association with Alzheimer's disease: independent confirmation using denaturing gradient gel electrophoresis. Neurology 1994; 44: 339-341.
25. Utermann G, Hees M, Steinmetz A. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man. Nature 1977; 269: 604-607.
26. Pang CP, Baum L, Chan WM, Lau TC, Poon PM, Lam DS. The apolipoprotein E epsilon4 allele is unlikely to be a major risk factor of age-related macular degeneration in Chinese. Ophthalmologica 2000; 214: 289-291.
27. Pablos-Méndez A, Mayeux R, Ngai C, Shea S, Berglund L. Association of apo E polymorphism with plasma lipid levels in a multiethnic elderly population. Arterioscler Thromb Vasc Biol 1997; 17: 3534-3541.
28. Woo D, Kaushal R, Chakraborty R, Woo J, Haverbusch M, Sekar P, Kissela B, Pancioli A, Jauch E, Kleindorfer D, Flaherty M, Schneider A, Khatri P, Sauerbeck L, Khoury J, Deka R, Broderick J. Association of apolipoprotein E4 and haplotypes of the apolipoprotein E gene with lobar intracerebral hemorrhage. Stroke 2005; 36: 1874-1879.
29. Brewer Jr HB, Zech LA, Gregg RE, Schwartz D, Schaefer EJ. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment. Ann Intern Med 1983; 98: 623-640.
30. Yang R, Powell-Braxton L, Ogaoawara AK, Dybdal N, Bunting S, Ohneda O, Jin H. Hypertension and endothelial dysfunction in apolipoprotein E knockout mice. Arter-ioscler Thromb Vasc Biol 1999; 19: 2762-2768.
31. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988; 8: 1-21.
32. Humphries SE, Talmud PJ, Hawe E, Bolla M, Day IN, Miller GJ. Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study. Lancet 2001; 358: 115-119.